Abstract
The aim of this study was to determine the pattern of the effect of the 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitor atorvastatin on cardiovascular events in patients with type 2 diabetes and no prior history of cardiovascular disease (CVD).
Original language | English |
---|---|
Pages (from-to) | 2482-2485 |
Number of pages | 4 |
Journal | Diabetologia |
Volume | 48 |
Issue number | 12 |
DOIs | |
Publication status | Published - 2005 |